On Tuesday shares of Threshold Pharmaceuticals Inc. (NASDAQ:THLD) closed at $4.06. Roth Capital set a $4.50 price objective on CTI BioPharma Corp (NASDAQ:CTIC) in a research report released on Monday morning. The firm currently has a a buy rating on the stock.
On Tuesday shares of Eli Lilly and Company (NYSE:LLY) closed at $72.65. Company’s sales growth for last 5 years was -2.10% and EPS growth for next 5 years is recorded as 5.65%. Suffering from generic competition and patent losses, Eli Lilly and Company (NYSE:LLY) froze salaries and cut bonuses last year–from the top management ranks on down. But the decreases in incentive pay didn’t make a huge dent in those executive pay packages. For CEO John Lechleiter, salary held steady at $1.5 million. His stock awards also stood firm at $6.75 million. His incentive pay did sink by more than $1 million, to $1.8 million from $2.9 million.
On last trading day Hasbro Inc. (NASDAQ:HAS) advanced 1.07% to close at $63.24. Its volatility for the week is 2.10% while volatility for the month is 1.80%. HAS’s sales growth for past 5 years was 1.00% and its EPS growth for past 5 years was 5.20%. Hasbro Inc. (NASDAQ:HAS) monthly performance is 0.14%. Hasbro Inc. (NASDAQ:HAS) announced that it will webcast its first quarter 2015 earnings conference call on Monday, April 20, 2015 at 8:30 a.m. Eastern Time, following the release of Hasbro’s financial results.
Merck & Co. Inc. (NYSE:MRK) in last trading activity moved down -1.47% to close at $57.48. Company weekly performance is -1.96% while its quarterly performance stands at 0.37%. Merck & Co. Inc. (NYSE:MRK) is -8.92% away from its 52 week high. Another day, another immuno-oncology tie up, and this time it’s Merck & Co Inc. (NYSE:MRK) and Syndax combining two of their anti-cancer drugs in the hope of magnifying their power. The collaboration will see Merck’s checkpoint inhibitor Keytruda (pembrolizumab) tested in combination with Syndax’ entinostat in a Phase Ib/II clinical programme in melanoma and non-small cell lung cancer, that could be extended into Phase III.
On last trading day Forestar Group Inc. (NYSE:FOR) decreased -0.76% to close at $15.77. Its volatility for the week is 2.19% while volatility for the month is 2.59%. FOR’s sales growth for past 5 years was 16.00% and its EPS growth for past 5 years was -28.30%. Forestar Group Inc. (NYSE:FOR) monthly performance is 8.53%. Forestar Group Inc. (NYSE:FOR) has set a May 12 date for its annual shareholders meeting, at which major changes to the Austin company’s board of directors will be put to a vote.